Menu
16 Apr 2026

Norton Rose Fulbright Advises Rothschild on Charterhouse's £235 Million Recommended Offer for Animalcare Group

"Norton Rose Fulbright advised Rothschild & Co, acting as financial adviser to Charterhouse Capital Partners and CCP Paw2 Bidco, on Charterhouse’s recommended £235 million cash offer for Animalcare Group plc."

Norton Rose Fulbright advised Rothschild & Co, acting as financial adviser to Charterhouse Capital Partners LLP and CCP Paw2 Bidco Limited, in connection with Charterhouse’s recommended £235 million cash offer for Animalcare Group plc. Charterhouse is one of the longest-established private equity firms operating in Europe, with over 80 years of active investments in private equity and more than 35 years of buy-outs. The firm typically invests in companies headquartered in Western Europe and works closely with incumbent management teams to drive growth. Charterhouse has approximately €7 billion of funds under management and follows a selective, conviction-led approach to investing in high-quality mid-market companies headquartered in Europe. The firm has 65 team members, including 17 partners and 35 investment professionals, all based at its London headquarters. Headquartered in York, UK, Animalcare is an animal healthcare company focused on the development and commercialisation of products for companion animals, equine and production animals. The company has approximately 165 animal health pharmaceutical brands across multiple markets and therapeutic areas, with a core focus on pain management, anaesthetics and analgesics, fluid therapy, gastric ulcer and non-antibiotic anti-infectives, and dental products. Animalcare has an established presence in Europe and has recently expanded into the APAC region through its acquisition of Randlab. Animalcare Group plc is traded on AIM under the ticker ANCR. Norton Rose Fulbright represented Rothschild & Co, acting as financial adviser to Charterhouse Capital Partners LLP and CCP Paw2 Bidco Limited, with a team composed by: Paul Whitelock, corporate partner, and Katherine MacPhail, corporate associate.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.